Anonymous Opposition, Lenacapavir, (Wo/2025/029247)
No Annotations
Alert me when there are new annotations for this document
5 similar patent oppositions
-
People PLUS opposition, Rilpivirine, (EA202391454)
Countries: Europe (EPO) Date: 2025
-
AIDS HEALTHCARE FOUNDATION [AHF] opposition, Lenacapavir, (202017007904)
Countries: India Date: 2025
-
LEK Pharmaceuticals opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)
Countries: Europe (EPO) Date: 2016
-
Page White & Farrer opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)
Countries: Europe (EPO) Date: 2016
-
ter Meer Steinmeister & Partner opposition, Dolutegravir/Abacavir/Lamivudine , (EP2531027)
Countries: Europe (EPO) Date: 2016